H.S Pharmaceuticals LTD

H.S Pharmaceuticals LTD
Contents Page
For the year ended 28 February 2025

Accountants' report	1
Statement of financial position	2
Notes to the financial statements	3

H.S Pharmaceuticals LTD Accountants' Report For the year ended 28 February 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Sovereign Accountants 28 February 2025 .................................................... Sovereign Accountants 6 Blenheim Court Peppercorn Close Peterborough PE1 2DU 08 October 2025 1

H.S Pharmaceuticals LTD
Accountants' Report
For the year ended 28 February 2025

Accountant’s report
You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Sovereign Accountants
28 February 2025

....................................................

Sovereign Accountants
6 Blenheim Court
Peppercorn Close
Peterborough
PE1 2DU
08 October 2025

1

H.S Pharmaceuticals LTD
Statement of Financial Position
As at 28 February 2025

	2025 £	2024 £
Current assets
Debtors	10,850	4,543
Cash at bank and in hand	4	504
	10,854	5,047
Creditors: amount falling due within one year	(5,998)	(5,709)
Net current assets	4,856	(662)

Total assets less current liabilities	4,856	(662)
Net assets	4,856	(662)

Capital and reserves
Called up share capital	1	1
Profit and loss account	4,855	(663)
Shareholders' funds	4,856	(662)

For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 08 October 2025 and were signed by:

-------------------------------
Haider Shamim
Director

2

H.S Pharmaceuticals LTD
Notes to the Abridged Financial Statements
For the year ended 28 February 2025

General Information

H.S Pharmaceuticals LTD is a private company, limited by shares, registered in , registration number 14657510, registration address 495 Gladstone Street, PE1 2DQ.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 1 (2024 : 0).

3

Registered Number: 14657510

H.S PHARMACEUTICALS LTD

Abridged Accounts

Period of accounts Start date: 29 February 2024 End date: 28 February 2025